Top Ten Issues in Health Law Podcast Series
Each year, AHLA identifies the top ten issues in health law that will have the greatest impact on the industry and partners with health law experts to bring you analysis and commentary on those issues.
Top Ten 2023
This special 10-part series, based on January's "Top Ten Issues in Health Law 2023" article in Health Law Connections magazine, brings together thought leaders from across the industry to delve deeper into the top ten issues of 2023.
1. Reproductive Health Rights in a Post-Roe Era
Carol Carden, Managing Principal of Valuation Services, PYA, speaks with Devon Minnick, Associate, Epstein Becker Green PC, about the continued effects of the Dobbs decision on the health law landscape. They discuss state efforts to restrict or protect abortion access, conflict between state and federal law, and the impact on providers and employers.
2. Health Care Antitrust Enforcement Trends and Outlook
David McMillan, Chief Financial Officer and Managing Principal of Consulting Services, PYA, speaks with Dionne Lomax, Managing Director of Antitrust and Trade Regulation, Affiliated Monitors, Inc., about the major health care antitrust enforcement trends to watch out for. They discuss the FTC’s recent proposed rule banning employment non-competes, the DOJ’s track record on criminal prosecutions, and merger enforcement developments.
3. Telehealth Trends to Watch
Martie Ross, Office Managing Principal, PYA, speaks with Jeremy Sherer, Partner, Hooper Lundy & Bookman PC, about some of the top telehealth trends to watch out for. They discuss Medicare coverage and reimbursement issues, state law and scope of practice developments, and controlled substances prescribing laws.
4. Implications of the CMS Framework for Health Equity
Deborah Biggs, Principal, PYA, speaks with Dawn Hunter, Director, Southeastern Region Office, Network for Public Health Law, about the recent CMS Framework for Health Equity 2022-2032 and the Executive Order to which it is responsive. They discuss the priorities in the Framework, some examples of guidance for providers and institutions, and how organizations can work toward health equity.
5. Fraud & Abuse Issues to Watch
Shannon Sumner, Chief Compliance Officer and Office Managing Principal, PYA, speaks with Chris Sabis, Member, Sherrard Roe Voigt & Harbison PLC, about some of the top fraud and abuse issues to watch out for. They discuss government enforcement activities and priorities, DOJ's increased focus on health IT and electronic health records, and the government’s approach to sub-regulatory guidance.
6. Data Privacy Requirements
Barry Mathis, Principal, PYA, speaks with Valerie Breslin Montague, Partner, Nixon Peabody LLP, about the new data privacy laws that have just been released. They discuss how health care entities and providers can remain compliant with the new laws and prepared for possible data breaches, considerations for telehealth programs, and risks for hybrid workforces.
7. Long Term Care Reforms
Anna Bhat, Office Managing Principal, PYA, speaks with Bill Hopkins, Partner, Spencer Fane LLP, about recent government initiatives to reform the U.S. post-acute care industry. They discuss some of the challenges currently facing the post-acute care industry, the presidential directives announced by the Biden Administration, and potential issues around private equity.
8. Drug Pricing and the Shift to Non-Institutional Care Settings
Jane Jerzak, Principal, PYA, speaks with Todd Nova, Attorney, Hall Render Killian Heath & Lyman PC, about key developments related to drug pricing and regulation of the pharmaceutical delivery system. They discuss the effects of recent changes to the 340B program, the impacts of American Hospital Association v. Becerra and the Inflation Reduction Act, and how drug manufacturers and providers are reacting.
9. ESG-Related Matters
Deborah Biggs, Principal, PYA, speaks with Michael W. Peregrine, Partner, McDermott Will & Emery LLP, and Anne M. Murphy, Partner, ArentFox Schiff LLP, about some of the recent developments related to environmental, social, and corporate governance (ESG) in the health care industry. They discuss the political and regulatory environment; issues related to tax-exempt status, health equity, climate risk, and workforce culture; and what to expect going forward.
10. Research-Related Developments to Watch
Tynan Kugler, Principal, PYA, speaks with Rebecca Schaefer, Partner, K&L Gates LLP, about research-related policy initiatives and regulatory changes to watch. They discuss the FDA’s September 2022 Noticed of Proposed Rulemaking, Biden Administration initiatives including the Cancer Moonshot and investment in cancer-focused clinical trial networks, the efforts of the newly formed Advanced Research Projects Agency for Health, and developments related to Presidential Memo 33 on research security.
Thank You to Our Top Ten 2023 Podcast Series Sponsor
AHLA would like to thank PYA for their support of this podcast series:
Top Ten Issues in Health Law 2023 Article
This special 10-part podcast series is based on the "Top Ten Issues in Health Law 2023" article, featured in the January issue of Health Law Connections.